Amir E - Search Results

1

Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: current status and future directions.

Ocaña A, Amir E. Ocaña A, et al. Among authors: amir e. Cancer Treat Rev. 2009 Dec;35(8):685-91. doi: 10.1016/j.ctrv.2009.08.001. Epub 2009 Sep 4. Cancer Treat Rev. 2009. PMID: 19733440 Review.

2

Prevalence of overt metastases in locally advanced breast cancer.

Al-Husaini H, Amir E, Fitzgerald B, Wright F, Dent R, Fralick J, Clemons M. Al-Husaini H, et al. Among authors: amir e. Clin Oncol (R Coll Radiol). 2008 Jun;20(5):340-4. doi: 10.1016/j.clon.2008.03.006. Clin Oncol (R Coll Radiol). 2008. PMID: 18420394

3

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.

Amir E, Ooi WS, Simmons C, Kahn H, Christakis M, Popovic S, Kalina M, Chesney A, Singh G, Clemons M. Amir E, et al. Clin Oncol (R Coll Radiol). 2008 Dec;20(10):763-8. doi: 10.1016/j.clon.2008.08.005. Epub 2008 Sep 27. Clin Oncol (R Coll Radiol). 2008. PMID: 18824337

4

Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

Amir E, Whyne C, Freedman OC, Fralick M, Kumar R, Hardisty M, Clemons M. Amir E, et al. Clin Exp Metastasis. 2009;26(5):479-84. doi: 10.1007/s10585-009-9247-x. Epub 2009 Mar 6. Clin Exp Metastasis. 2009. PMID: 19266291

5

Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?

Freedman OC, Amir E, Clemons MJ. Freedman OC, et al. Among authors: amir e. Crit Rev Oncol Hematol. 2009 Oct;72(1):56-64. doi: 10.1016/j.critrevonc.2009.03.001. Epub 2009 Mar 23. Crit Rev Oncol Hematol. 2009. PMID: 19307138 Review.

6

Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer.

Amir E, Trinkaus M, Simmons CE, Dranitsaris G, Clemons MJ. Amir E, et al. J Clin Pathol. 2009 May;62(5):474-6. doi: 10.1136/jcp.2008.062505. J Clin Pathol. 2009. PMID: 19398598 Clinical Trial.

7

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.

Freedman O, Amir E, Dranitsaris G, Napolskikh J, Kumar R, Fralick M, Chia S, Petrella T, Dent S, Tonkin K, Ahmad I, Rayson D, Clemons M. Freedman O, et al. Among authors: amir e. Breast Cancer Res Treat. 2009 Nov;118(2):377-83. doi: 10.1007/s10549-009-0452-8. Epub 2009 Jun 24. Breast Cancer Res Treat. 2009. PMID: 19551499

8

Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

Simmons C, Amir E, Dranitsaris G, Clemons M, Wong B, Veith R, Cole DE. Simmons C, et al. Among authors: amir e. Anticancer Res. 2009 Jul;29(7):2707-11. Anticancer Res. 2009. PMID: 19596950

9

Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.

Cawthorn TR, Amir E, Broom R, Freedman O, Gianfelice D, Barth D, Wang D, Holen I, Done SJ, Clemons M. Cawthorn TR, et al. Among authors: amir e. Clin Exp Metastasis. 2009;26(8):935-43. doi: 10.1007/s10585-009-9284-5. Epub 2009 Aug 21. Clin Exp Metastasis. 2009. PMID: 19697143

10

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer.

Freedman OC, Amir E, Hanna W, Kahn H, O'Malley F, Dranitsaris G, Cole DE, Verma S, Folkerd E, Dowsett M, Clemons M. Freedman OC, et al. Among authors: amir e. Breast Cancer Res Treat. 2010 Jan;119(1):155-61. doi: 10.1007/s10549-009-0523-x. Breast Cancer Res Treat. 2010. PMID: 19731013 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results